US PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis

Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available in the United States. Oxford, United Kingdom – March 23,…

Continue ReadingUS PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis

Optellum named by the UK government as one of the top 100 digital health companies

Healthcare UK, part of the Department for International Trade (DIT), has launched a programme to showcase the UK's leading digital health companies.  Digital Health and Artificial Intelligence is seen as the answer to many of the challenges facing global…

Continue ReadingOptellum named by the UK government as one of the top 100 digital health companies

Optellum’s lung cancer prediction AI is clinically validated in the top-ranked US respiratory journal

Global leading doctors from Vanderbilt and Oxford have published independent clinical validation of the Optellum Lung Cancer Prediction AI, illustrating its potential to shorten time to diagnosis. The paper, with…

Continue ReadingOptellum’s lung cancer prediction AI is clinically validated in the top-ranked US respiratory journal